1-3 of 3
Renaud Prudent
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of BCR-ABL1 Tyrosine Kinase Inhibitors with a Small Molecule LIM kinase1/2 Inhibitor in BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

Thorsten Braun, MD PhD, Jeannig Berrou, Renaud Prudent, Hanane Djamai, Melanie Dupont, Anna Kaci, Emilie Adiceam, Fabrice Paublant, Andre Baruchel, MD, Jacques Ghysdael, Claude Gardin, Herve Dombret
Journal: Blood
Blood (2018) 132 (Supplement 1): 2705.
https://doi.org/10.1182/blood-2018-99-115933
Published: 2018
Journal Articles

Role of LIM Kinase in Oncogenic Signaling from FLT3 and KIT Receptors and Its Targeting in Myeloid Leukemia

Ruchi Pandey, PhD, Raghuveer Mali, PhD, Anindya Chatterjee, MS,PhD, Fabrice Paublant, Renaud Prudent, Laurence Lafanechere, Reuben Kapur, PhD
Journal: Blood
Blood (2015) 126 (23): 1257.
https://doi.org/10.1182/blood.V126.23.1257.1257
Published: 2015
Journal Articles

Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations

Nicolas Ricard, Marie Bidart, Christine Mallet, Gaetan Lesca, Sophie Giraud, Renaud Prudent, Jean-Jacques Feige, Sabine Bailly
Journal: Blood
Blood (2010) 116 (9): 1604–1612.
https://doi.org/10.1182/blood-2010-03-276881
Published: 2010